Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders - Wikidata - wikimedia - TriplyDB

Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders

Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders

http://www.wikidata.org/entity/Q36119800

about

Practical approach to the patient with hypereosinophilia Update on eosinophilic meningoencephalitis and its clinical relevance Novel Therapies for Eosinophilic Disorders Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field The internal architecture of leukocyte lipid body organelles captured by three-dimensional electron microscopy tomography Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes.What targeting eosinophils has taught us about their role in diseases.IL-4 engagement of the type I IL-4 receptor complex enhances mouse eosinophil migration to eotaxin-1 in vitro.Unraveling the complexity of lipid body organelles in human eosinophils.Enhanced tissue factor expression by blood eosinophils from patients with hypereosinophilia: a possible link with thrombosis.Human versus mouse eosinophils: "that which we call an eosinophil, by any other name would stain as red".Advances in diagnosis and treatment of eosinophilia Eosinophils: changing perspectives in health and disease.Interface Molecules of Angiostrongylus cantonensis: Their Role in Parasite Survival and Modulation of Host Defenses.Biomarkers of eosinophil involvement in allergic and eosinophilic diseases: review of phenotypic and serum markers including a novel assay to quantify levels of soluble Siglec-8 Contributions of electron microscopy to understand secretion of immune mediators by human eosinophils.Piecemeal degranulation in human eosinophils: a distinct secretion mechanism underlying inflammatory responses Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TREAD).Eosinophilic cystitis presented as a manifestation of hypereosinophilic syndrome: a case report and review of the literature Novel targeted therapies for eosinophilic disorders ICON: Eosinophil Disorders Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.Recurrent cutaneous necrotizing eosinophilic vasculitis: a case report and review of the literature.Management of hypereosinophilia in tropical settings.Eosinophils in mucosal immune responses Vesicle-mediated secretion of human eosinophil granule-derived major basic protein.Guideline for the investigation and management of eosinophilia.Parasitic Hypereosinophilia in Childhood: a Diagnostic Challenge.

P2860

Q24610994-110D48D0-472C-4563-A095-C1386EBDE772 Q24643008-886B718B-ADF0-4AF4-8C5E-450E6484A6CD Q26799600-3E1B5D5F-7ACF-4696-926C-058D534C1239 Q27003331-866608F1-4E74-47A3-B709-C19D5FDA32D5 Q27333495-513C39DB-9CCD-4F9E-860C-22010BDD7663 Q33881297-29987641-2A20-4DD6-A40F-3A2CEF5B6B39 Q33987218-253DCDD9-9763-4447-8A91-C4BF50B1DF05 Q34326427-499FDC71-5687-4FCB-9CDE-178B86573C24 Q34341337-1386670D-A9ED-4668-9E26-1BEEA8EFB8AC Q34465853-F09CCCC7-7BCF-4825-A839-EADECE0A53EC Q34641855-475C1886-1FCF-410F-83AF-83C5167B12AC Q34895664-3DFF79C1-AE53-4251-90A5-234029DAC2B0 Q35170969-F539BD69-9AE4-46E8-BC31-7FF4E240BDD7 Q35875174-F3C8E815-159E-4D4E-94DD-B814A6D4B609 Q36139731-D81EDDF8-98CE-49F8-B7E4-279583FE9E46 Q36169557-2AD78EC4-5316-47A0-A295-5235835B1271 Q36188927-B61E1137-23BD-4932-9741-9A2A47BF452A Q36206063-86FFDC73-AE1A-4591-85B0-D41E6DBF5821 Q36744360-2F5A65FE-E8F9-4238-922F-564E789E84CF Q36763565-B91798E5-E74F-4855-937B-E5AB05030DB2 Q36834826-F1F9B72C-6DB0-4606-8672-113F7B9E072F Q37343465-AA69D953-CD03-4A72-AD87-B502C1D3F274 Q37418128-DB3EAEB2-7F47-4870-8C36-612FBDC76EF6 Q38327667-E658B644-9538-476D-B761-4A9E3AC292BB Q38390424-5670EB24-820A-43C0-898B-6EC54435D468 Q43105476-806E56A1-F4BB-4188-B252-A5555D746FC4 Q55059996-CED6E4C1-BBAD-4410-8074-611E211474DB Q55260651-B53971D4-13E5-4ED3-B0AE-BFC08261F34F

P2860

Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders

http://www.wikidata.org/entity/Q36119800

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders

@ast

Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders

@en

type

label

Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders

@ast

Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders

@en

prefLabel

Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders

@ast

Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders

@en

P1433

Q36119800-78620C52-778C-410F-B009-58FF1DECBFAC

P1476

Q36119800-6F8EFEAF-4C1A-4746-B0DB-AB84A45DFE24

P2093

Q36119800-13CAF3BC-54EA-4C1D-B513-A27C1642C74F

Q36119800-C739CDF6-3C23-49C2-97DF-0938719A4C5F

P2860

Q36119800-035288A0-CD49-441D-B2C8-102169E5E62F

Q36119800-0501D25C-47EB-4E85-A1F1-8E2227B0F9A8

Q36119800-09C0E6D2-B447-40F9-B881-67451584EB23

Q36119800-0AC6D104-7D8D-4490-AD3F-A887A93878AB

Q36119800-112C39A8-7250-4BC3-AA2A-847AEDC1E509

Q36119800-12BF6BC4-A707-439B-9098-C83996C61EE2

Q36119800-13098025-EAC2-40B0-8535-7988DEE14B77

Q36119800-13707B93-B585-4A35-9A32-2532D87D8D9D

Q36119800-1655EC22-F17D-4BA7-8303-AF45DDBF4F72

Q36119800-1816E49C-3373-41EB-B93E-BE0612B22BC0

P304

Q36119800-AFC9425E-EA62-42BF-B5D0-EDBD2F2D8C87

P31

Q36119800-7F06922F-5ABD-4881-B30D-78CAFC528B9A

P356

Q36119800-B86EA323-03F2-48BE-BF2F-B6398908631F

P433

Q36119800-F7DCEAE5-5255-4CFA-923E-EEA889A3B3A1

P478

Q36119800-B09582E3-EA02-42C1-BB11-4997211F0675

P577

Q36119800-66DACCE1-F1DD-44C2-99F2-7F9D44AE10A3

P5875

Q36119800-45779C0B-C9D2-4369-B530-D9E8E9C833AB

P698

Q36119800-BEE12FC5-7C0D-42BC-9D90-91C0FCC2A71A

P932

Q36119800-2CAD4E40-512F-40D2-A723-C44DB1E137B5

P356

J.IAC.2007.07.004

P1433

Immunology and Allergy Clinics of North America

P1476

Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders

@en

P2093

Bruce S Bochner

http://www.w3.org/2001/XMLSchema#string

Steven J Ackerman

http://www.w3.org/2001/XMLSchema#string

P2860

Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2

Essential and instructive roles of GATA factors in eosinophil development

Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils

Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors

Analysis of the CCR3 promoter reveals a regulatory region in exon 1 that binds GATA-1

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.

Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils

Eosinophil granule proteins in peripheral blood granulocytes

Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis

Novel combinatorial interactions of GATA-1, PU.1, and C/EBPepsilon isoforms regulate transcription of the gene encoding eosinophil granule major basic protein

P304

357-375

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IAC.2007.07.004

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5971568

http://www.w3.org/2001/XMLSchema#string

P698

17868854

http://www.w3.org/2001/XMLSchema#string

P932

2064859

http://www.w3.org/2001/XMLSchema#string